Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updat... by Chen, Yuanbin, Reinmuth, Niels, Hotta, Katsuyuki, Özgüroğlu, Mustafa, Ji, Jun Ho, Garassino, Marina Chiara, Poltoratskiy, Artem, Ponce, Santiago, Bondarenko, Igor, Conev, Nikolay V, Armstrong, Jon, Byrne, Natalie, Jiang, Haiyi, Paz-Ares, Luis, Voitko, Nataliia, Poltoratskiy, Artem, Bondarenko, Igor, Chen, Yuanbin, Özgüroglu, Mustafa, Conev, Nikolay, Burghuber, Otto, Moiseenko, Vladimir, Reinmuth, Niels, Ursol, Grygorii, Pajkos, Gábor, Verderame, Francesco, Smolin, Alexey, Göksel, Tuncay, Dakhil, Shaker, Lee, Jong-Seok, Garcia Campelo, Maria Rosario, Alacacioglu, Ahmet, Casarini, Ignacio, Ilieva, Rumyana, Somfay, Attila, Roila, Fausto, Urda, Michal, Majem Tarruella, Margarita, Bettini, Anna Cecilia, Okamoto, Isamu, Mandziuk, Slawomir, Domine Gomez, Manuel, Wu, Shang-Yin, Knoble, Jeanna, Venkova, Violetka, Laack, Eckart, Bischoff, Helge, Fülöp, Andrea, Telekes, András, Kanda, Shintaro, Nakahara, Yasuharu, Lin, Sheng-Hao, Schaefer, Eric, Nikolinakos, Petros, Schneider, Jeffrey, Kultan, Juraj, Kolek, Vitezslav, Lee, Kyung Hee, Goloborodko, Olexandr, Kolesnik, Oleksii, Ostapenko, Yuriy, Stilwill, Joseph, De Marchi, Pedro Rafael Martins, Krasteva, Rositsa, Koubkova, Leona, Grohe, Christian, Heching, Norman Isaac, Harada, Daijiro, Nogami, Naoyuki, Nokihara, Hiroshi, Goto, Hisatsugu, Staal van den Brekel, Agnes, Ganea, Doina, Popova, Ekaterina, Sakaeva, Dina, Stresko, Marian, Demo, Pavol, Hsia, Te-Chun, Lee, Kang-Yun, Zarba, Juan Jose, Pastor, Andrea Viviana, Zukin, Mauro, Calabrich, Aknar, Dudov, Asen, Lang, Susanne, Kanazawa, Kenya, Hiltermann, Jeroen, Shparyk, Yaroslav, Kryzhanivska, Anna, Jamil, Rodney, Williamson, Michael, Han, Zhigang, Wang, Mengzhao, Li, Wei, Feng, Jifeng, Zhou, Xiangdong, Hu, Yi, Nan, Kejun, Zhang, Wei, Lin, Zhong

Get full text

Survival outcomes of the NeoALTTO study (BIG 1–06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast c... by Huober, Jens, Holmes, Eileen, Baselga, José, de Azambuja, Evandro, Untch, Michael, Fumagalli, Debora, Sarp, Severine, Lang, Istvan, Smith, Ian, Boyle, Frances, Xu, Binghe, Lecocq, Christophe, Wildiers, Hans, Jouannaud, Christelle, Hackman, John, Dasappa, Lokanatha, Ciruelos, Eva, Toral Pena, Juan Carlos, Adamchuk, Hryhoriy, Hickish, Tamas, de la Pena, Lorena, Jackisch, Christian, Gelber, Richard D., Piccart-Gebhart, Martine, Di Cosimo, Serena

Get full text

Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equiv... by Xu, Binghe, Zhang, Qingyuan, Sun, Tao, Li, Wei, Teng, Yue’e, Hu, Xichun, Bondarenko, Igor, Adamchuk, Hryhoriy, Zhang, Liangming, Trukhin, Dmytro, Wang, Shusen, Zheng, Hong, Tong, Zhongsheng, Shparyk, Yaroslav, Wang, Qingyu

Get full text

Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomise... by Hurvitz, Sara A, Bardia, Aditya, Quiroga, Vanesa, Park, Yeon Hee, Blancas, Isabel, Alonso-Romero, José Luis, Vasiliev, Aleksandr, Adamchuk, Hryhoriy, Salgado, Marcelo, Yardley, Denise A, Berzoy, Oleksandr, Zamora-Auñón, Pilar, Chan, David, Spera, Gonzalo, Xue, Cloris, Ferreira, Erika, Badovinac Crnjevic, Tanja, Pérez-Moreno, Pablo Diego, López-Valverde, Vanesa, Steinseifer, Jutta, Fernando, Tharu M, Moore, Heather M, Fasching, Peter A

Get full text

Abstract P1-18-08: Trazimera (a trastuzumab biosimilar) in HER2-positive metastatic breast cancer: Long-term safety and overall survival data by Li, Rubi K, Lipatov, Oleg, Adamchuk, Hryhoriy, Vladimirov, Vladimir, Yanez, Eduardo, Banchero, Patricia, Freyman, Amy, Hilton, Fiona, Thiele, Alexandra, Vana, Alicia

Get full text

Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer: Updated Results of a Randomized, Dou... by Li, Rubi K., Tokunaga, Eriko, Adamchuk, Hryhoriy, Vladimirov, Vladimir, Yanez, Eduardo, Lee, Keun Seok, Bondarenko, Igor, Vana, Alicia, Hilton, Fiona, Ishikawa, Tomofumi, Tajima, Kentaro, Lipatov, Oleg

Get full text

Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Docetaxel-Induced Neutropenia in Patients With Solid Tumors: A Randomized Clinical Trial by Blayney, Douglas W, Mohanlal, Ramon, Adamchuk, Hryhoriy, Kirtbaya, Dmitry Valikovich, Chen, Michael, Du, Lihua, Ogenstad, Stephan, Ginn, Greg, Huang, Lan, Zhang, Qingyuan

Get full text

Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Stud... by Trukhin, Dmytro, Poddubskaya, Elena, Andric, Zoran, Makharadze, Tamta, Bellala, Ravi Shankar, Charoentum, Chaiyut, Yañez Ruiz, Eduardo P., Fulop, Andrea, Hyder Ali, Irfhan Ali, Syrigos, Kostas, Katgi, Nuran, Lopez Chuken, Yamil Alonso, Rumyana, Ilieva, Reyes-Igama, Jasmin, Costamilan, Rita de Cassia, Del Campo García, Ana, Florez, Amalia, Paravisini, Alexandra, Millan, Susana

Get full text